AstraZeneca Investor Conference Presentation Deck

16 Investor Relations Andy Barnett Head of Investor Relations [email protected] Morgan Sanford Oncology [email protected] Philip Sparks BioPharmaceuticals (R&I, V&I), Other medicines [email protected] Rachel Korolyshun Rare Disease, ESG [email protected] Josie Afolabi Oncology [email protected] Christer Gruvris BioPhamaceuticals (CVRM), Finance and Fixed Income [email protected] Lauren Swales Rare Disease, ESG [email protected] B